Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
US-9249089-B2 · Feb 2, 2016 · US
US9884809B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9884809-B2 |
| Application number | US-201514877974-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 8, 2015 |
| Priority date | Dec 17, 2010 |
| Publication date | Feb 6, 2018 |
| Grant date | Feb 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds and compositions thereof are also provided.
Opening claim text (preview).
What is claimed is: 1. A compound of the formula: wherein: R 1 and R 2 are each methyl; and R 3 ,R 4 ,R 5 and R 6 are each independently: hydrogen, hydroxy or amino, or alkyl (c≦12) , acyl (c≦12) , alkoxy (c≦12) , aryloxy (c≦12) , alkylamino (c≦12) , dialkylamino (c≦12) , amido (c≦12) , or a substituted version of any of these groups; or a pharmaceutically acceptable salt or tautomer thereof. 2. The compound of claim 1 , wherein R 4 ,R 5 and R 6 are each hydrogen. 3. The compound of claim 1 , wherein R 3 is hydroxy. 4. The compound of claim 1 , wherein R 3 is alkoxy (c≦6) or substituted alkoxy (c≦6) . 5. The compound of claim 4 , wherein R 3 is substituted alkoxy (c≦6) . 6. The compound of claim 5 , wherein R 3 is methoxymethoxy. 7. The compound of claim 1 , wherein carbon atom 10 is in the R configuration. 8. The compound of claim 1 , wherein carbon atom 10 is in the S configuration. 9. The compound of claim 1 , wherein carbon atom 5 is in the R configuration. 10. The compound of claim 1 , wherein carbon atom 5 is in the S configuration. 11. The compound of claim 1 , further defined as:
Free radical scavengers or antioxidants · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
condensed with carbocyclic rings or ring systems · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.